The Elevator Pitch: Sell Them on Your Idea, Your Product, Your Company, You!Read more
NSIV member, Cellanyx Diagnostics, was awarded the best prostate cancer biomarker poster presentation at the recent 2016 American Urological Association annual meeting. “Cellanyx is currently developing phenotypic tests to address an important unmet clinical need in prostate cancer risk stratification by providing quantitative assessment of tumor aggressiveness and metastatic potential that complements the standard-of-care GleasonRead more
NSIV member, CrowdComfort, was featured in the WSJ last week in an article about high tech approaches being used to resolve the constant battle around the office thermostat. In addition to reporting uncomfortable conditions, CrowdComfort’s app leverages crowd-sourced occupant feedback to improve safety and operations in workplaces, unlock efficiencies in facilities management and preventative maintenance, increase employeeRead more
Thrive Bioscience, a manufacturer of automated cell culture management systems, and the Harvard Stem Cell Institute (HSCI), Cambridge, Massachusetts, announced an agreement last week under which Thrive will develop instruments for the growth and maintenance of induced pluripotent stem cells (iPSCs). The agreement includes development of automated iPSC protocols critical to HSCI and its researchers.Read more
Woman-led technology incubator will boost efforts to support entrepreneurs developing biotech and cleantech startups BEVERLY, Massachusetts, September 1, 2016. North Shore InnoVentures (NSIV), one of New England’s leading technology incubators and business accelerators, announced today that it received a highly competitive award for $50,000 from U.S. Small Business Administration’s Accelerator Growth Fund Competition. NSIV was oneRead more
August 25th, 2016 Funding will go towards expanding the region’s biotech industry with a new business incubator space Salem, MA – Today, the Office of Congressman Seth Moulton (D-MA) announced that the U.S. Department of Commerce¹s Economic Development Administration (EDA) has awarded a $1.4 million dollar grant to Endicott College and North Shore InnoVentures in Beverly. ThisRead more
Pittsburgh based Sharp Edge Labs, a former NSIV member company, announced that it has entered into a drug discovery collaboration agreement with Sumitomo Dainippon Pharma Co. Ltd. Sharp Edge focuses on discovering drugs to treat genetic disorders of protein trafficking. CEO Scott Sneddon explained that the collaboration “takes advantage of the synergy between Sumitomo DainipponRead more
Interested in incubating your company with NSIV? Submit your application today!